🏃 Grab this Black Friday offer early. Get up to 55% off InvestingPro now!CLAIM SALE

Pfizer Inc (PFE)

Lima
Currency in USD
26.50
-0.38(-1.41%)
Delayed Data

PFE Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa40,90541,65181,288100,33058,496
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+0.2%+1.82%+95.16%+23.43%-41.7%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa7,8478,38530,68634,09723,989
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa33,05833,26650,60266,23334,507
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.46%+0.63%+52.11%+30.89%-47.9%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa80.82%79.87%62.25%66.02%58.99%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa24,91623,47523,62227,23729,248
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+1.29%-5.78%+0.63%+15.3%+7.38%
aa.aaaa.aaaa.aaaa.aaaa.aa7,7218,70910,36011,42810,679
aa.aaaa.aaaa.aaaa.aaaa.aa12,76611,4189,56212,20013,836
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa8,1429,79126,98038,9965,259
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.7%+20.25%+175.56%+44.54%-86.51%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa19.9%23.51%33.19%38.87%8.99%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-1,128-1,098-1,089-673-109
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-54.52%+2.66%+0.82%+38.2%+83.8%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-1,573-1,449-1,291-1,238-2,209
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa4453512025652,100
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1,3821,9372,3751,9021,944
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa8,39610,63028,26640,2257,094
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa32-237--222
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-4,574-3,019-3,848-1,998-3,849
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa11,3207,03624,31034,7291,058
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+214.88%-37.84%+245.51%+42.86%-96.95%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa27.67%16.89%29.91%34.61%1.81%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa5833701,8523,328-1,115
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa16,0559,19522,02431,4072,158
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-29-36-45-35-39
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa16,0269,15921,97931,3722,119
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+43.69%-42.85%+139.97%+42.74%-93.25%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa39.18%21.99%27.04%31.27%3.62%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa1----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa10,7076,63022,41331,3662,134
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.921.1945.590.38
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+195.23%-37.92%+235.28%+39.77%-93.24%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.891.183.935.470.37
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+194.85%-37.46%+233.05%+39.19%-93.24%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa5,5695,5555,6015,6085,643
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa5,6755,6325,7085,7335,709
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa1.441.521.561.61.64
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.88%+5.56%+2.63%+2.56%+2.5%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa13,85714,45532,08444,02411,517
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2.9%+4.32%+121.96%+37.21%-73.84%
EBITDA Margin %
aa.aaaa.aaaa.aa